United Kingdom · Question · Written question
UIN 61708
TRIPS Agreement: Coronavirus
Original
Introduced
12 October 2022
Last action
17 October 2022 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
17 October 2022
Summary
To ask the Secretary of State for International Trade, what assessment she had made of the potential merits of including (a) covid-19 treatments, and (b) diagnostics in the Trade-Related Aspects of Intellectual Property Rights waiver negotiation.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
12 October 2022
Written question
To ask the Secretary of State for International Trade, what assessment she had made of the potential merits of including (a) covid-19 treatments, and (b) diagnostics in the Trade-Related Aspects of Intellectual Property Rights waiver negotiation.
Source: Commons
17 October 2022
Answer
The UK is engaging in the ongoing discussions taking place in the World Trade Organization, as Members consider extending the TRIPS Decision to COVID-19 therapeutics and diagnostics. The UK approach will be evidence based.
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department for International Trade · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2022-10-12/61708
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1521393
- uk · wq-1521393 · source updated 17 October 2022